CAS: 2188-67-2; Noepain

英文名称Noepain
中文名称2-(戊基氨基)乙基4-氨基苯甲酸酯
IUPAC名称Benzoic acid, p-amino-, 2-(pentylamino)ethyl ester
其它别名Ethanol,2-(pentylamino)-, 4-aminobenzoate (ester) (9CI); Ethanol, 2-(pentylamino)-,p-aminobenzoate (7CI); Ethanol, 2-(pentylamino)-, p-aminobenzoate (ester)(8CI); Naepaine (6CI); 2-n-Amylaminoethyl p-aminobenzoate; 2-n-Pentylaminoethylp-aminobenzoate; Amalcaine; Amylcain; Amylcaine; Amylsin; Amylsine; Naopaine; p-Aminobenzoic acid 2-n-amylaminoethyl ester; p-Aminobenzoic acid2-n-pentylaminoethyl ester
CAS编号2188-67-2
FDA UNII编号:J1Z219971C
分子式:C14H22N2O2分子量:250.34
产品CID: 1137474
产品分类有机原料 → 苯类化合物 → 苯取代衍生物

相似结构搜索
产品信息参考;
InChIKey: UYXHCVFXDBNRQW-UHFFFAOYSA-N
1S/C14H22N2O2/c1-2-3-4-9-16-10-11-18-14(17)12-5-7-13(15)8-6-12/h5-8,16H,2-4,9-11,15H2,1H3
计算化学: 氢键受体数4.0氢键供体数2.0可旋转键数9.0

物理性质

熔点66°
沸点393.47°C (粗估)
闪点197.3ºC
密度1.0390 (粗估)
pKa:9.22±0.19(预测)
LogP:3.1
折射率1.5110 (估算)
外观形态固体
储存条件Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
产品应用该化合物是一种生化物.

MSDS等安全信息

合成工艺路线路线简述

📜Alkaline Earth Salt Of/the/ Methylsulfuric Acid置于水,钯体系中,化学反应生成2-(戊基氨基)乙基4-氨基苯甲酸酯
参考文献:Benzoates,P-Aminobenzoates And Phenylurethans Of 2-Alkylaminoethanols
标题:Benzoates,P-Aminobenzoates And Phenylurethans Of 2-Alkylaminoethanols
摘要:
Doi:10.1021/ja01237A009

海关参考信息

2906210000-苄醇
2912110000-甲醛
2912210000-苯甲醛
2915110000-甲酸
💡 提示：海关信息按照顺序优先匹配，如需确认的海关信息，请参考相关资料。
详情请参考：📖 海关编码查询和海关进出口税则

专利信息

专利号:US-7993390-B2
优先权日:2002-02-08
标题:Implantable or insertable medical device resistant to microbial growth and biofilm formation
发明人：MILLER KATHLEEN M; BUCAY-COUTO WEENNA; LI JIANMIN
权利人:BOSTON SCIENT SCIMED INC
摘要:Disclosed are implantable or insertable medical devices that provide resistance to microbial growth on and in the environment of the device and resistance to microbial adhesion and biofilm formation on the device. In particular, the invention discloses implantable or insertable medical devices that comprise at least one biocompatible matrix polymer region, an antimicrobial agent for providing resistance to microbial growth and/or a microbial adhesion/biofilm synthesis inhibitor for inhibiting the attachment of microbes and the synthesis and accumulation of biofilm on the surface of the medical device. Also disclosed are methods of manufacturing such devices under conditions that substantially prevent preferential partitioning of any of said bioactive agents to a surface of the biocompatible matrix polymer and substantially prevent chemical modification of said bioactive agents.